MiniMed Group, Inc. (MMED): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of MMED were reported in the last 12 months. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling MiniMed Group
From the latest filingsOverall: more buying than selling. Funds mostly bought. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns MMED
97 funds and institutions reported MMED shares worth $560M at the end of Q2 2026, about 13% of the company. The largest holder is Massachusetts Financial Services Co with 3.0%.
Funds and institutions (13F) 13%Everyone else 87%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Massachusetts Financial Services Co | 8.33M | 2.97% | $125M | +21% |
| Millennium Management LLC | 3.06M | 1.09% | $45.8M | +18% |
| Citadel Advisors LLC | 2.87M | 1.02% | $42.8M | +0% |
| Longaeva Partners L.P. | 2.81M | 1.00% | $42.1M | -12% |
| Sessa Capital IM, L.P. | 2.00M | 0.71% | $29.9M | No change |
| BlackRock, Inc. | 2.00M | 0.71% | $29.8M | +7527% |
| Norges Bank | 1.96M | 0.70% | $29.3M | New |
| Rock Springs Capital Management LP | 1.52M | 0.54% | $22.7M | +44% |
| ExodusPoint Capital Management, LP | 1.44M | 0.51% | $21.5M | +251% |
| FMR LLC (Fidelity) | 1.08M | 0.38% | $16.2M | -21% |
| Geode Capital Management, LLC | 956,024 | 0.34% | $14.3M | +289% |
| Boston Partners | 902,359 | 0.32% | $13.5M | +7% |
| J. Goldman & Co LP | 830,218 | 0.30% | $12.4M | New |
| Nuveen, LLC | 539,313 | 0.19% | $8.1M | New |
| UBS Group AG | 413,416 | 0.15% | $6.2M | +33% |
| State Street Corp | 403,289 | 0.14% | $6M | New |
| Healthcare of Ontario Pension Plan Trust Fund | 375,000 | 0.13% | $5.6M | -50% |
| First Trust Advisors LP | 366,268 | 0.13% | $5.5M | +269% |
| Vanguard Capital Management LLC | 323,325 | 0.12% | $4.8M | New |
| Burkehill Global Management, LP | 300,000 | 0.11% | $4.5M | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
No MMED insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MMED short interest
Low short interest. 3.5% of MMED shares are sold short: about 1 share in 29. Over the last 12 reports the number of shares short went up 130%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 9.81M MMED shares were sold short, 3.5% of the shares outstanding, down 52.8% from the report before. At the average daily volume of 10.25M shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 9.81M | 3.49% | -53% | 10.25M | 1.0 |
| Oct 15, 2026 | 20.70M | 7.36% | +14% | 23.12M | 1.0 |
| Sep 30, 2026 | 18.20M | 6.47% | +34% | 3.09M | 5.9 |
| Sep 15, 2026 | 13.59M | 4.83% | +69% | 2.81M | 4.8 |
| Aug 31, 2026 | 8.06M | 2.87% | +37% | 1.38M | 5.8 |
| Aug 14, 2026 | 5.90M | 2.10% | -2% | 1.03M | 5.7 |
| Jul 31, 2026 | 6.03M | 2.15% | -5% | 1.27M | 4.8 |
| Jul 15, 2026 | 6.35M | 2.26% | -3% | 843,381 | 7.5 |
| Jun 30, 2026 | 6.57M | 2.34% | +44% | 1.52M | 4.3 |
| Jun 15, 2026 | 4.56M | 1.63% | +13% | 1.12M | 4.1 |
| May 29, 2026 | 4.04M | 1.44% | -5% | 636,778 | 6.3 |
| May 15, 2026 | 4.28M | 1.52% | +17% | 595,292 | 7.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
MiniMed Group company events
MiniMed Group filed 11 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, control). The latest was on Oct 16, 2026.
- Oct 16, 2026ControlThe previously announced exchange offer of up to an aggregate of 252,813,348 newly issued shares of common stock of MiniMed Group, Inc. in exchange for outstanding ordinary shares of Medtronic plc was completed. Filing
- Oct 13, 2026VoteReported shareholder vote results. Filing
- Sep 1, 2026ResultsReleased financial results. Filing
- Aug 5, 2026LeadershipCourtney Nelson Wills, Senior Vice President, General Counsel and Corporate Secretary, notified MiniMed Group, Inc. of her decision to resign from her position, effective September 25, 2026, following an 8-week transition period. Filing
- Jun 29, 2026LeadershipThe Board of Directors of MiniMed Group, Inc. increased the size of the Board from nine to 11 and appointed David Endicott and Linnea Burman to serve as a directors of the Board to fill the resulting vacancies, effective June 29, 2026. Filing
- Jun 3, 2026ResultsReleased financial results. Filing
- May 18, 2026LeadershipBrett Wall, a class II director of the Board of Directors of MiniMed Group, Inc. and member of the Board’s Nominating and Corporate Governance Committee, notified the Board that he will resign from the Board effective July 3, 2026. Filing
- Apr 27, 2026AnnouncementShared information with investors. Filing
- Mar 27, 2026LeadershipThe Compensation and Talent Committee of the Board of Directors of MiniMed Group, Inc. approved the MiniMed Severance Pay Plan for Executives and applicable severance benefit practices and levels that would be applicable to the Company’s named executive officers and the MiniMed Group, Inc. Change… Filing
- Mar 25, 2026AnnouncementShared information with investors. Filing
- Mar 9, 2026LeadershipReconstitution of the Board In connection with the Separation, effective as of March 6, 2026, Brian Sandstrom resigned from the Company’s board of directors, and the size of the Board was increased from one to nine members. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
MiniMed Group financials
Famous investors that hold MMED
4 of the 50 well-known investors we track reported holding MMED in their latest 13F filing. The largest position is Israel Englander's, worth $29.9M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 1.53M | $29.9M | 0.0% | -50% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.13M | $22M | 0.0% | -60% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 751,848 | $14.6M | 0.0% | +4784% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 159,700 | $3.1M | 0.0% | +81% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named MMED in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 6, 2026 | FMR LLC | 13G | 13.5% |
| Nov 6, 2026 | FMR LLC | 13G | 13.5% |
| Oct 22, 2026 | Capital Ventures International | 13G | 7.8% |
| Oct 22, 2026 | Capital Ventures International | 13G | 7.8% |
| Oct 16, 2026 | Medtronic plc | 13G/A | 0.0% |
| Oct 16, 2026 | Medtronic plc | 13G/A | 0.0% |
Questions about MiniMed Group, Inc. (MMED) stock
Who owns the most MMED stock?
The largest reported owner of MiniMed Group, Inc. (MMED) is Massachusetts Financial Services Co, with 3.0% of the company. In total, 97 funds and institutions reported holding MMED at the end of Q2 2026, together about 13% of the shares. See the largest owners.
Are MMED insiders buying or selling?
No MMED insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in MMED?
As of Oct 30, 2026, 9.81M MMED shares were sold short, 3.5% of the shares outstanding, down 52.8% from the report before. At the average daily volume of 10.25M shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold MMED?
4 of the 50 well-known investors we track reported MMED in their latest 13F filing, including Israel Englander, Ken Griffin, Steve Cohen. The largest position is worth $29.9M. See all holders.
Executive pay
MiniMed Group's chief executive was paid a total of $8.4M for the year ended Apr 24, 2026. In the last 12 months, MiniMed Group's executives and directors bought no stock on the open market and sold none.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.